An Official Website of the United States Government
Company Information:
Name:
ARTIFICIAL CELL TECHNOLOGIES, INC.
Address:
5 Science Park, 3rd Floor
NEW HAVEN, CT
NEW HAVEN, CT
Located in HUBZone:
No
Woman-Owned:
No
Minority-Owned:
No
URL:
N/A
Phone:
N/A
Award Totals:
Award List:
Polypeptide Multilayer Nanofilms for Synthetic Biomatrix Development
Award Year / Program / Phase:
2009 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Award Amount:
$331,582.00
Abstract:
DESCRIPTION (provided by applicant): This SBIR Phase I project will determine the feasibility of applying polypeptide multilayer nanofilm technology to synthetic biomatrix development and commercialization. These nanofilms are a type of surface coating for cell and tissue culture. Immediate in vitro… More
Synthetic nanocapsule malaria vaccines
Award Year / Program / Phase:
2010 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Thomas J. Powell
Award Amount:
$600,000.00
Abstract:
DESCRIPTION (provided by applicant): The goal of this project is to produce novel synthetic malaria vaccines based on epitopes of the circumsporozoite (CS) protein of Plasmodium falciparum, the causative agent of human malaria. Malaria is one of the major
diseases in the developing world, causing… More
Synthetic nanoparticle vaccines for RSV
Award Year / Program / Phase:
2011 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Thomas J. Powell – 203-772-3430
Award Amount:
$600,000.00
Abstract:
DESCRIPTION (provided by applicant): Respiratory syncytial virus (RSV) is the most important cause of severe lower respiratory tract illness in infants and the elderly. There is no approved vaccine despite decades of effort. Early attempts to develop a formalin- inactivated vaccine (FI-RSV) resulted… More